The following 2020 continuing education courses have been approved by the Texas Optometry Board to renew licenses for 2021.
Professional Responsibility Courses taken on the Internet count as Internet Hours.
A licensee may receive a maximum of 8 hours credit for Internet Courses.
A few of the listed courses may include Professional Responsibility Hours (see table above). Please note that grand rounds courses may have a start date of January 1, 2020.
Optometrists prescribing or dispensing Schedule III opioids are required to take a one hour board approved continuing education course covering best practices, alternative treatment options, and multi-modal approaches to pain management that may include physical therapy, psychotherapy, and other treatments to renew for 2021.
If you do not see a course listed, please e-mail or call the Board at 512-305-8500, to inquire about the status of that course. The hours listed are the maximum number of hours presented. Options may be available to take fewer than the listed hours. This list is provided for the convenience of license holders. The course provider has provided information concerning dates and contact procedures. Please confirm any information with the provider. The Board cannot be responsible for the accuracy of this information. Use this link for General CE Information.
“Approval” of continuing education courses by the Texas Optometry Board is based on the course meeting the requirements of Section 351.308 of the Optometry Act. The Board does not make a determination regarding provisions of Optometry Act Section 351.457 (splitting fees). The Board does not make a determination regarding federal law such as the False Claims Act, the Anti-Kickback Statute, the Stark Law, the Exclusion Statute, and the Civil Monetary Penalties Law. Additional information on the federal laws may be obtained from the Office of Inspector General (OIG) for the U.S. Department of Health & Human Services. The OIG has published a booklet, A Roadmap for New Physicians: Avoiding Medicare and Medicaid Fraud and Abuse